Antitumor efficacy of 26-fluoroepothilone B against human prostate cancer xenografts.
Newman RA, Yang J, Raymond M, Finlay V, Cabral F, Vourloumis D, Stephens LC, Troncoso P, Wu X, Logothetis CJ, Nicolaou KC, Navone NM.
Newman RA, et al. Among authors: vourloumis d.
Cancer Chemother Pharmacol. 2001 Oct;48(4):319-26. doi: 10.1007/s002800100323.
Cancer Chemother Pharmacol. 2001.
PMID: 11710633